UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome

Hormone and metabolic research, 2012-09, Vol.44 (9), p.694

2012

Volltextzugriff (PDF)

Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study

Clinical endocrinology (Oxford), 2014-06, Vol.80 (6), p.884-889

2014

Volltextzugriff (PDF)

Strength Training and Testosterone Treatment Have Opposing Effects on Migration Inhibitor Factor Levels in Ageing Men

Mediators of Inflammation, 2013-01, Vol.2013, p.539156-7

2013

Volltextzugriff (PDF)

Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double‐blinded, placebo‐controlled trial

Andrology (Oxford), 2018-07, Vol.6 (4), p.547-555

2018

Volltextzugriff (PDF)

Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat

Hormone and metabolic research, 2013-04, Vol.45 (4), p.308

2013

Volltextzugriff (PDF)

Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome

Journal of endocrinological investigation, 2013-07, Vol.36 (7), p.460-465

2013

Volltextzugriff (PDF)

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials

BMJ open, 2014-10, Vol.4 (10), p.e005708-e005708

2014

Volltextzugriff (PDF)

Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes

Diabetes (New York, N.Y.), 2007-06, Vol.56 (6), p.1592-1599

2007

Volltextzugriff (PDF)

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life

Fertility and sterility, 2017-03, Vol.107 (3), p.788-795.e2

2017

Volltextzugriff (PDF)

Significantly Higher Adrenocorticotropin-Stimulated Cortisol and 17-Hydroxyprogesterone Levels in 337 Consecutive, Premenopausal, Caucasian, Hirsute Patients Compared with Healthy Controls

The journal of clinical endocrinology and metabolism, 2005-03, Vol.90 (3), p.1347-1353

2005

Volltextzugriff (PDF)

Myocardial response to a triathlon in male athletes evaluated by Doppler tissue imaging and biochemical parameters

Scandinavian journal of medicine & science in sports, 2008-12, Vol.18 (6), p.698-705

2008

Volltextzugriff (PDF)

O-315 Familial endocrine disease increases the risk of pregnancy loss and recurrent pregnancy loss– a nationwide register-based study of 366,548 Danish women

Human reproduction (Oxford), 2024-07, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden

Human reproduction (Oxford), 2024-08, Vol.39 (8), p.1823-1834

2024

Volltextzugriff (PDF)

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome

Human reproduction (Oxford), 2014-08, Vol.29 (8), p.1773-1779

2014

Volltextzugriff (PDF)

The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS

Human reproduction (Oxford), 2017-11, Vol.32 (11), p.2279-2286

2017

Volltextzugriff (PDF)

Prevalence and incidence of clinically diagnosed knee, hip and hand osteoarthritis in women with polycystic ovary syndrome: a National Register-Based Study

Osteoarthritis and cartilage, 2018-04, Vol.26, p.S200-S200

2018

Volltextzugriff (PDF)

F417 GROUP COUNSELLING AND PHYSICAL ACTIVITY OF PATIENTS WITH POLYCYSTIC OVARIAL SYNDROME (PCOS)

European journal of pain supplements, 2011-09, Vol.5 (1), p.156-156

2011

Volltextzugriff (PDF)

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Human reproduction (Oxford), 2016-12, Vol.31 (12), p.2791-2795

2016

Volltextzugriff (PDF)

Higher blood pressure in normal weight women with PCOS compared to controls

Endocrine Connections, 2021-02, Vol.10 (2), p.154-163

2021

Volltextzugriff (PDF)

The relationship between health-related quality of life, obesity and testosterone levels in older men

Age and ageing, 2014-03, Vol.43 (2), p.280-284

2014

Volltextzugriff (PDF)

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Human reproduction (Oxford), 2017-04, Vol.32 (4), p.966-966

2017

Volltextzugriff (PDF)

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss

Minerva endocrinologica, 2013-03, Vol.38 (1), p.59

2013

Volltextzugriff (PDF)

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis

Fertility and sterility, 2004-12, Vol.82 (6), p.1570-1579

2004

Volltextzugriff (PDF)

Prescription of antidepressants is increased in D anish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population‐based cohort study

Clinical endocrinology (Oxford), 2014-06, Vol.80 (6), p.884-889

2014

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(62)
Tagungsberichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome

Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study

Strength Training and Testosterone Treatment Have Opposing Effects on Migration Inhibitor Factor Levels in Ageing Men

Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double‐blinded, placebo‐controlled trial

Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat

Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials

Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life

Significantly Higher Adrenocorticotropin-Stimulated Cortisol and 17-Hydroxyprogesterone Levels in 337 Consecutive, Premenopausal, Caucasian, Hirsute Patients Compared with Healthy Controls

Myocardial response to a triathlon in male athletes evaluated by Doppler tissue imaging and biochemical parameters

O-315 Familial endocrine disease increases the risk of pregnancy loss and recurrent pregnancy loss– a nationwide register-based study of 366,548 Danish women

Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden

Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome

The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS

Prevalence and incidence of clinically diagnosed knee, hip and hand osteoarthritis in women with polycystic ovary syndrome: a National Register-Based Study

F417 GROUP COUNSELLING AND PHYSICAL ACTIVITY OF PATIENTS WITH POLYCYSTIC OVARIAL SYNDROME (PCOS)

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Higher blood pressure in normal weight women with PCOS compared to controls

The relationship between health-related quality of life, obesity and testosterone levels in older men

Should we individualize lipid profiling in women with polycystic ovary syndrome?

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis

Prescription of antidepressants is increased in D anish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population‐based cohort study

Aktive Filter

Suchergebnisse filtern